IPP Bureau

Cupid to set up FMCG manufacturing facility in Saudi Arabia
Cupid to set up FMCG manufacturing facility in Saudi Arabia

By IPP Bureau - December 30, 2025

The plant is expected to enhance regional supply capabilities

Astal signs LoI with Immuna Therapeutics
Astal signs LoI with Immuna Therapeutics

By IPP Bureau - December 30, 2025

Astal estimates the collaboration will generate incremental revenue of approximately Rs. 300 crore upon implementation

Next Gen Diagnostics to spin off infection prevention unit
Next Gen Diagnostics to spin off infection prevention unit

By IPP Bureau - December 29, 2025

NGD Infection Prevention was formed to scale the delivery of sequence-based transmission detection

Quantum BioPharma completes key toxicity studies for Lucid-MS, paving way for Phase 2 MS trial
Quantum BioPharma completes key toxicity studies for Lucid-MS, paving way for Phase 2 MS trial

By IPP Bureau - December 29, 2025

Lucid-MS represents a potential breakthrough in the treatment of multiple sclerosis

SN Bioscience’s SNB-101 wins FDA orphan drug designation for gastric cancer
SN Bioscience’s SNB-101 wins FDA orphan drug designation for gastric cancer

By IPP Bureau - December 29, 2025

The drug, currently in a phase 1b/2 clinical trial for small cell lung cancer, is a polymer nanoparticle formulation of SN-38

WuXi Biologics wins HERA 2025 Award for outstanding ESG disclosure
WuXi Biologics wins HERA 2025 Award for outstanding ESG disclosure

By IPP Bureau - December 29, 2025

The company views ESG reporting as a strategic tool to build trust with clients, investors, regulators, and stakeholders worldwide

CPHI & PMEC India 2025 ignites pharma innovation and partnerships
CPHI & PMEC India 2025 ignites pharma innovation and partnerships

By IPP Bureau - December 29, 2025

For 2026 onwards, CPHI and PMEC India are evolving into two distinct, specialized shows

ENHERTU gains first-ever nod in China for metastatic breast cancer
ENHERTU gains first-ever nod in China for metastatic breast cancer

By IPP Bureau - December 29, 2025

The approval follows results from the DESTINY-Breast06 phase 3 trial, which showed ENHERTU significantly extended progression-free survival compared to chemotherapy

Singlera Genomics partners with Pure Medical to bring early cancer detection to Europe
Singlera Genomics partners with Pure Medical to bring early cancer detection to Europe

By IPP Bureau - December 29, 2025

Singlera and Pure Medical will team up with local universities, hospital networks, and national healthcare systems across Western Europe for research studies

Govt cancels registration of popular cosmetic product over misleading claims
Govt cancels registration of popular cosmetic product over misleading claims

By IPP Bureau - December 29, 2025

The cancellation underscores the regulator’s strict stance against misleading cosmetic claims

US House passes Bill reauthorizing FDA rare disease incentive program
US House passes Bill reauthorizing FDA rare disease incentive program

By IPP Bureau - December 29, 2025

Akums and Sharda University ink MoU to bridge industry–academia gap
Akums and Sharda University ink MoU to bridge industry–academia gap

By IPP Bureau - December 29, 2025

The primary goal of the collaboration is joint research into trending and next-generation molecules

Lupin and Gan & Lee enter exclusive licensing deal for novel GLP-1 receptor agonist
Lupin and Gan & Lee enter exclusive licensing deal for novel GLP-1 receptor agonist

By IPP Bureau - December 29, 2025

Lupin has bolstered its diabetes and obesity portfolios by securing an agreement for Bofanglutide, a GLP-1 receptor agonist developed by Gan & Lee Pharmaceuticals

Intas and IntegriMedical to launch India’s first needle-free injection system for IVF and gynaecology
Intas and IntegriMedical to launch India’s first needle-free injection system for IVF and gynaecology

By IPP Bureau - December 29, 2025

Intas becomes the first and only company in India to offer IVF and gynecology therapies with needle-free injections

Briefs: CuraTeQ Biologics, Sigachi Industries and Natural Capsules
Briefs: CuraTeQ Biologics, Sigachi Industries and Natural Capsules

By IPP Bureau - December 28, 2025

CuraTeQ Biologics and BioFactura USA to terminate agreement mutually

Latest Stories

Interviews

Packaging